Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01090934
Other study ID # 2009-A00574-53
Secondary ID
Status Completed
Phase N/A
First received February 5, 2010
Last updated January 26, 2016
Start date October 2009
Est. completion date November 2013

Study information

Verified date January 2016
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

Multicenter prospective study comparing the diagnosis value of high-resolution EEG and depth-EEG to localize the epileptogenic zone in drug resistant partial epilepsies.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date November 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 15 Years and older
Eligibility Inclusion Criteria:

- medically intractable patial epilepsy confirmed by video-EEG recordings of epileptic seizures.

- Depth EEG (Stereo-EEG) required to delineate the epileptogenic zone and define the surgical procedure.

- full informed consent of the patient (or of his/ her legal representative)

- 15 year or older patient

Exclusion Criteria:

- contraindication to cortectomy

- contraindication to depth-EEG

- indication of epilepsy surgery without depth-EEG monitoring

- high grade glioma, arterio-veinous malformations

- pregnancy

- history of severe cardio-vascular event (coronaropathy, stroke)

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
High Resolution EEG
High Resolution EEG
Stereo-electroencephalography
SEEG

Locations

Country Name City State
France University Hospital of Marseille Marseille
France Central Hospital Nancy

Sponsors (5)

Lead Sponsor Collaborator
Central Hospital, Nancy, France CHU de Reims, France: Centre National de la Recherche Scientifique, Institut National de la Santé Et de la Recherche Médicale, France, University Hospital, Marseille

Country where clinical trial is conducted

France, 

References & Publications (4)

Koessler L, Benar C, Maillard L, Badier JM, Vignal JP, Bartolomei F, Chauvel P, Gavaret M. Source localization of ictal epileptic activity investigated by high resolution EEG and validated by SEEG. Neuroimage. 2010 Jun;51(2):642-53. doi: 10.1016/j.neuroimage.2010.02.067. Epub 2010 Mar 4. — View Citation

Koessler L, Cecchin T, Caspary O, Benhadid A, Vespignani H, Maillard L. EEG-MRI co-registration and sensor labeling using a 3D laser scanner. Ann Biomed Eng. 2011 Mar;39(3):983-95. doi: 10.1007/s10439-010-0230-0. Epub 2010 Dec 8. — View Citation

Koessler L, Salido-Ruiz R, Ranta R, Louis-Dorr V, Gavaret M, Maillard L. Influence of source separation and montage on ictal source localization. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2898-901. doi: 10.1109/IEMBS.2010.5626321. — View Citation

Maillard L, Koessler L, Colnat-Coulbois S, Vignal JP, Louis-Dorr V, Marie PY, Vespignani H. Combined SEEG and source localisation study of temporal lobe schizencephaly and polymicrogyria. Clin Neurophysiol. 2009 Sep;120(9):1628-36. doi: 10.1016/j.clinph.2009.06.022. Epub 2009 Jul 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity and specificity of electrical source localization of inter-ictal and ictal discharges using high-Resolution EEG for localizing the epileptogenic zone (the stereo-electroencephalography will be the reference method) results of electrical sources localization of inter-ictal and ictal discharges are compared to the epileptogenic zone defined by SEEG 3 years No
Secondary inter-observer reliability of electrical source localization of inter-ictal and ictal discharges for localizing the epileptogenic zone. sources localization of inter-ictal and ictal discharges will be interpreted by two independant epileptologists, blinded to the results of stereo-EEG. 3 years No
Secondary sensitivity and specificity of high resolution EEG and electrical source imaging for surgical decision decision of surgery and the limits of the cortectomy established with electrical source imaging will be compared to the decision of surgery and the limits of the cortectomy established with Stereo-electroencephalography. 3 years No
See also
  Status Clinical Trial Phase
Withdrawn NCT00982787 - Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy Phase 2
Completed NCT00898560 - Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive Phase 1
Recruiting NCT01735032 - Multimodal Imaging in Pre-surgical Evaluation of Epilepsy N/A
Terminated NCT00391534 - EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy Phase 3
Terminated NCT01496612 - Buspirone Therapy for Localized Epilepsy Phase 2
Completed NCT00900237 - Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine Phase 1
Recruiting NCT04903314 - Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Phase 1
Completed NCT01373190 - Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy N/A
Completed NCT00894478 - Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging N/A
Recruiting NCT03478852 - Investigating Epilepsy: Screening and Evaluation
Recruiting NCT01273129 - Surgery as a Treatment for Medically Intractable Epilepsy
Completed NCT00001666 - Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy N/A
Completed NCT00001932 - Serotonin Receptors in Seizure Disorders N/A
Completed NCT00908349 - Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy Phase 3
Completed NCT02076698 - Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy Phase 3
Completed NCT00706160 - Language Mapping in Patients With Epilepsy
Completed NCT01397968 - Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures Phase 2
Completed NCT01866111 - A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Phase 2
Completed NCT00957047 - Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy Phase 3
Terminated NCT01281956 - PRX-00023 Therapy in Localization-Related Epilepsy Phase 2